Citation

Pharm. J. 2005; 275(7370): e429.

Copyright

(Copyright © 2005, Pharmaceutical Press)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

adolescent; human; child; depression; suicide attempt; suicidal behavior; clinical trial; risk assessment; behavior disorder; patient monitoring; note; practice guideline; drug safety; placebo; risk benefit analysis; disease exacerbation; irritability; drug information; high risk patient; attention deficit disorder; drug surveillance program; agitation; atomoxetine